1. CIC 1436, Team Pharmacologie en Population, Cohortes et Biobanques, and
2. Department of Internal Medicine, Toulouse University Hospital, Toulouse, France;
3. Department of Internal Medicine, Adult Immune Cytopenias, Henry Mondor Hospital, Assistance Publique Hôpitaux de Paris, Paris-Est Créteil University, Créteil, France;
4. Department of Medical and Clinical Pharmacology, Centre of Pharmacovigilance, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Paris-Est Créteil University, Créteil, France;
5. Centre of Pharmacovigilance, Rouen University Hospital, Rouen, France;
6. Regional Pharmacovigilance Center, Besançon University Hospital, Besançon, France;
7. Pharmacovigilance Center, Hospital University Pharmacotoxicology Department, Hospices Civils de Lyon, Lyon, France;
8. Department of Medical and Clinical Pharmacology, Centre of Pharmacovigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France;
9. Department of Medical Pharmacology, Centre of Pharmacovigilance, Bordeaux University Hospital, Bordeaux, France; and
10. INSERM, BPH, U1219, Team Pharmacoepidemiology, University of Bordeaux, Bordeaux, France